| Patients undergoing MTH procedure | Control group | p |
---|---|---|---|
 | (n = 32) | (n = 33) |  |
Definite stent thrombosis* | 0 (0%) | 0 (0%) | ns |
Probable stent thrombosis* | 0 (0%) | 2 (7.4%) | ns |
Pneumonia | 19 (59.4%) | 19 (57.6%) | ns |
Positive blood culture | 12 (37.5%) | 11 (33.3%) | ns |
Bleeding of any severity | 8 (25.0%) | 5 (15.2%) | ns |
Red blood cell transfusion | 4 (12.5%) | 2 (6.1%) | ns |
Rhythm and conductions disorders: | Â | Â | ns |
  Atrial fibrillation | 6 (18.8%) | 7 (21.2%) | |
  Ventricular tachycardia | 3 (9.4%) | 1 (3.0%) | ns |
  Clinically relevant bradycardia | 3 (9.4%) | 1 (3.0%) | ns |